| Ligand‐directed signalling at β‐adrenoceptors BA Evans, M Sato, M Sarwar, DS Hutchinson, RJ Summers British journal of pharmacology 159 (5), 1022-1038, 2010 | 188 | 2010 |
| Myocardial oxidative stress contributes to transgenic β2‐adrenoceptor activation‐induced cardiomyopathy and heart failure Q Xu, A Dalic, L Fang, H Kiriazis, RH Ritchie, K Sim, XM Gao, ... British journal of pharmacology 162 (5), 1012-1028, 2011 | 131 | 2011 |
| Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis BSM Chow, M Kocan, S Bosnyak, M Sarwar, B Wigg, ES Jones, ... Kidney international 86 (1), 75-85, 2014 | 123 | 2014 |
| The actions of relaxin on the human cardiovascular system M Sarwar, XJ Du, TB Dschietzig, RJ Summers British Journal of Pharmacology 174 (10), 933-949, 2017 | 86 | 2017 |
| Serelaxin‐mediated signal transduction in human vascular cells: bell‐shaped concentration–response curves reflect differential coupling to G proteins M Sarwar, CS Samuel, RA Bathgate, DR Stewart, RJ Summers British journal of pharmacology 172 (4), 1005-1019, 2015 | 79 | 2015 |
| ML290 is a biased allosteric agonist at the relaxin receptor RXFP1 M Kocan, M Sarwar, SY Ang, J Xiao, JJ Marugan, MA Hossain, C Wang, ... Scientific reports 7 (1), 2968, 2017 | 55 | 2017 |
| Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats PJ Ryan, EV Krstew, M Sarwar, AL Gundlach, AJ Lawrence Drug and alcohol dependence 140, 8-16, 2014 | 37 | 2014 |
| Enhanced serelaxin signalling in co‐cultures of human primary endothelial and smooth muscle cells M Sarwar, CS Samuel, RA Bathgate, DR Stewart, RJ Summers British journal of pharmacology 173 (3), 484-496, 2016 | 34 | 2016 |
| Signalling profiles of H 3 relaxin, H 2 relaxin and R 3 (BΔ 23–27) R/I 5 acting at the relaxin family peptide receptor 3 (RXFP 3) M Kocan, M Sarwar, MA Hossain, JD Wade, RJ Summers British journal of pharmacology 171 (11), 2827-2841, 2014 | 32 | 2014 |
| In the loop: Extrastriatal regulation of spiny projection neurons by GPR52 DL Spark, M Mao, S Ma, M Sarwar, CJ Nowell, DM Shackleford, ... ACS Chemical Neuroscience 11 (14), 2066-2076, 2020 | 6 | 2020 |
| The actions of relaxin on the human cardiovascular system (vol 174, pg 933, 2017) M Sarwar, XJ Du, TB Dschietzig, RJ Summers BRITISH JOURNAL OF PHARMACOLOGY 174 (24), 4836-4836, 2017 | | 2017 |
| The mechanisms of action of relaxin in the human cardiovascular system M Sarwar Monash University, 2015 | | 2015 |
| DISTINCT SIGNALLING PROFILES PRODUCED BY SERELAXIN IN HUMAN VASCULAR CELLS R Summers, M Sarwar, C Samuel, R Bathgate BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 112-112, 2014 | | 2014 |
| RELAXIN INHERENTLY REQUIRES THE ANGIOTENSIN II TYPE 2 RECEPTOR TO ABROGATE RENAL FIBROSIS B Chow, M Kocan, S Bosnyak, M Sarwar, E Jones, R Widdop, R Summers, ... NEPHROLOGY 18, 36-36, 2013 | | 2013 |
| Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol PJ Ryan, EV Krstew, M Sarwar, AL Gundlach, AJ Lawrence, AJ Lawrence | | |
